CompletedPhase 4NCT04614311

Strategies Towards Personalised Treatment in Juvenile Idiopathic Arthritis (JIA).

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oslo University Hospital
Principal Investigator
Pernille H Bøyesen, MD PhD
Oslo University Hospital
Intervention
Triamcinolone Hexacetonide 20 MG/ML(drug)
Enrollment
189 target
Eligibility
1-18 years · All sexes
Timeline
20202025

Study locations (5)

Collaborators

The Research Council of Norway · Haukeland University Hospital · St. Olavs Hospital · University Hospital of North Norway · Helse Stavanger HF

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04614311 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials